EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Amalgamation of Biofilms and Synthetic Biology: A Paradigm Shift in Biotechnology

Durgananda Lahari Bhamidipaty, Veenadhari Bhamidipaty, Fayaz M Shaikh, Kanaka Durga Prasad Bhamidipaty, Rajesh Botchu

Medical Principles and Practice · 2026

DOI: 10.1159/000550994 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Principles and Practice, 2026. Verfasst von Durgananda Lahari Bhamidipaty und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Manipal Institute of Technology, Manipal, India. Hauptthemen laut MEDLINE: Biofilms, Synthetic Biology, Biotechnology. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biofilms are intricately organized microbial communities enveloped in self-produced extracellular polymeric substances. They display remarkable resilience to environmental and antimicrobial stresses and adhere to various surfaces. Synthetic biology, which combines molecular biology with engineering principles, offers tools to modulate biofilm behaviour for biotechnological applications and to address associated challenges. This review examines recent developments at the intersection of biofilm engineering and synthetic biology, highlighting strategies such as phage therapy, electrogenetic systems, microbial consortia design, quorum sensing regulation, genetic circuits, extracellular polymeric substances modification, and antimicrobial peptide-coated surfaces. These tools allow precise manipulation of biofilm structure, composition, and metabolic output. Biofilms are increasingly optimized for applications such as wastewater treatment, bioremediation, bioenergy, and diagnostics. Enhancements in stability and function are achieved via engineered circuits and extracellular polymeric substances adjustments, while antimicrobial approaches help control pathogenic biofilms. Despite these innovations, challenges remain, including biosafety, heterogeneity, scalability, and regulatory compliance. Continued interdisciplinary efforts are essential for translating these systems into viable technologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsSynthetic BiologyBiotechnologyQuorum SensingHumans

Stichwörter der Autor:innen

Antimicrobial peptidesBiofilmsBiologyBiotechnologyElectrogeneticsGenetic circuitsMicrobial consortiaQuorum sensingSynthetic biology

Autor:innen und Institutionen

  • Department of Biotechnology, Manipal Institute of Technology, Manipal, India.
  • Department of Computer Science and Engineering, Gitam Institute of Technology, Visakhapatnam, India.
  • Department of Radiodiagnosis, Anil Neerukonda Hospital (ANH), Visakhapatnam, India.
  • Department of Radiodiagnosis, Anil Neerukonda Hospital (ANH), Visakhapatnam, India, drrajeshb@gmail.com.
  • Department of Musculoskeletal Radiology, Royal Orthopedic Hospital, Birmingham, UK, drrajeshb@gmail.com.

Zitieren

APA

Bhamidipaty, D. L., Bhamidipaty, V., Shaikh, F. M., Bhamidipaty, K. D. P., & Botchu, R. (2026). Amalgamation of Biofilms and Synthetic Biology: A Paradigm Shift in Biotechnology. Medical Principles and Practice. https://doi.org/10.1159/000550994

Vancouver

Bhamidipaty DL, Bhamidipaty V, Shaikh FM, Bhamidipaty KDP, Botchu R. Amalgamation of Biofilms and Synthetic Biology: A Paradigm Shift in Biotechnology. Medical Principles and Practice. 2026. doi:10.1159/000550994

BibTeX
@article{Bhamidipaty2026,
  author = {Bhamidipaty, Durgananda Lahari and Bhamidipaty, Veenadhari and Shaikh, Fayaz M and Bhamidipaty, Kanaka Durga Prasad and Botchu, Rajesh},
  title = {Amalgamation of Biofilms and Synthetic Biology: A Paradigm Shift in Biotechnology},
  journal = {Medical Principles and Practice},
  year = {2026},
  doi = {10.1159/000550994}
}
Kostenlos starten →